selected publications
-
academic article
-
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
British Journal of Cancer.
118.
2018
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study.
International Journal of Epidemiology.
47.
2018
Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.
BMC Cancer.
18.
2018
Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
Pathology - Research and Practice.
214.
2018
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care.
Scandinavian Journal of Rheumatology.
47.
2018
Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.
Human Pathology.
80.
2018
Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
PLoS ONE.
13.
2018
Evidence of No Association Between Human Papillomavirus and Breast Cancer.
Frontiers in Oncology.
8.
2018
Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
BMC Cancer.
18.
2018
Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
PLoS ONE.
13.
2018
Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.
BMJ Open.
8.
2018
Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction.
OncoImmunology.
7.
2018
Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing.
Translational Oncology.
11.
2018
MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study.
Virchows Archiv.
473.
2018
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Mayo Clinic Proceedings.
93.
2018
The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
Cancer Cytopathology.
126.
2018
The genetic landscape of 87 ovarian germ cell tumors.
Gynecologic Oncology.
151.
2018
Triple negative breast cancer – prognostic role of immune-related factors: a systematic review.
Acta Oncologica.
57.
2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
PLoS ONE.
13.
2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
International Journal of Molecular Sciences.
19.
2018
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer.
Oncotarget.
5.
2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.
Oncotarget.
5.
2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci..
Oncotarget.
8.
2017
Annexin A2 and cancer: A systematic review.
International Journal of Oncology.
52.
2017
BMI‐1 protein expression as a negative independent prognostic factor in DLBCL.
Hematological Oncology.
35.
2017
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
International Journal of Cancer.
140.
2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
JAMA Oncology.
3.
2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
British Journal of Cancer.
116.
2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
Cancer Epidemiology Biomarkers & Prevention.
26.
2017
History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
Cancer Causes & Control.
28.
2017
History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.
British Journal of Cancer.
117.
2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
49.
2017
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
Cancer Epidemiology Biomarkers & Prevention.
26.
2017
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
American Journal of Epidemiology.
185.
2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.
Cancer Causes & Control.
28.
2017
Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project.
Contemporary Clinical Trials Communications.
8.
2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
British Journal of Cancer.
116.
2017
574P Prognostic mRNA expression signatures in whole blood in patients with metastatic colorectal cancer treated with 3rd line cetuximab and irinotecan.
Annals of Oncology.
27.
2016
95P Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan.
Annals of Oncology.
27.
2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
International Journal of Cancer.
139.
2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
International Journal of Epidemiology.
45.
2016
Approaches to the detection of ovarian cancer.
Abstracts of papers, meeting of the Finnish Medical Society.
245.
2016
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Human Genetics.
135.
2016
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.
Cancer Epidemiology Biomarkers & Prevention.
25.
2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Oncotarget.
7.
2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
Obstetrics and Gynecology.
127.
2016
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
International Journal of Epidemiology.
45.
2016
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal of the National Cancer Institute.
108.
2016
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
Cancer Epidemiology Biomarkers & Prevention.
25.
2016
Current status on microRNAs as biomarkers for ovarian cancer.
Apmis.
124.
2016
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk..
Human Molecular Genetics.
25.
2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus.
Nature Communications.
7.
2016
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Cancer Discovery.
6.
2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
Oncotarget.
7.
2016
HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.
Apmis.
124.
2016
Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.
Cytopathology.
27.
2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
Oncotarget.
5.
2016
Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups.
Blood.
128.
2016
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
141.
2016
Outcome of cetuximab plus irinotecan in relation to RAS and BRAF mutational status in patients with colorectal cancer prior treated with a fluoropyrimidine, oxaliplatin and irinotecan..
Journal of Clinical Oncology.
34.
2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Journal of Medical Genetics.
53.
2016
PD-001 Total cell-free DNA level in plasma as strong prognostic marker in metastatic colorectal cancer.
Annals of Oncology.
27.
2016
Quantification of fibronectin as a method to assess ex vivo extracellular matrix remodeling.
Biochemical and Biophysical Research Communications.
478.
2016
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
British Journal of Cancer.
115.
2016
The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.
Cancer Epidemiology.
41.
2016
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
Nature Communications.
6.
2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
PLoS ONE.
10.
2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Carcinogenesis.
36.
2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
Journal of Clinical Oncology.
33.
2015
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
Genetic Epidemiology.
39.
2015
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.
Gynecologic Oncology.
136.
2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Clinical Cancer Research.
21.
2015
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer.
Clinical Cancer Research.
21.
2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
47.
2015
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Cancer Epidemiology Biomarkers & Prevention.
24.
2015
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
British Journal of Cancer.
113.
2015
P-234The Intestinal Stem Cell Marker SOX9 Predicts Relapse of Stage II Colon Cancer Patients.
Annals of Oncology.
26.
2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Human Molecular Genetics.
24.
2015
Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the ‘Malova’ ovarian cancer study.
Apmis.
123.
2015
The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics.
Gynecologic Oncology.
136.
2015
ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer.
Journal of the National Cancer Institute.
106.
2014
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Molecular Nutrition & Food Research.
58.
2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
British Journal of Cancer.
111.
2014
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Human Genetics.
133.
2014
Individuals with complete filaggrin deficiency may have an increased risk of squamous cell carcinoma.
British Journal of Dermatology.
170.
2014
Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome.
Cancer Immunology Research.
2.
2014
Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10.
Cancer Research.
74.
2014
The nationwide Danish CancerBiobank: Future possibilies..
Journal of Clinical Oncology.
32.
2014
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer.
Cancer Epidemiology Biomarkers & Prevention.
23.
2014
-
dataset
-
Candidate miRNAs found on the ovarian cancer discovery cohort..
public-library-of-science.
2019
Demographics of pelvic mass patients on the two cohorts..
public-library-of-science.
2019
Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass.
public-library-of-science.
2019
Additional file 1: of Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
springer-nature.
2018
Additional file 3: of Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
springer-nature.
2018
Association of variants in small GTPase genes with epithelial ovarian cancer risk (p-value<10−4) and functional annotation..
public-library-of-science.
2018
Baseline characteristics of 198 patients with EOC..
public-library-of-science.
2018
Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications.
public-library-of-science.
2018
Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
public-library-of-science.
2018
Multivariate Cox regression analysis of miRNAs associated with PFS, OS and TTP..
public-library-of-science.
2018
Multivariate logistic regression analysis for chemotherapy resistance..
public-library-of-science.
2018
Univariate validation in GSE73581 cohort..
public-library-of-science.
2018
Univariate validation in the GSE25204+GSE73582 cohort..
public-library-of-science.
2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
public-library-of-science.
2018
data_sheet_1_Evidence of No Association Between Human Papillomavirus and Breast Cancer.PDF.
frontiers.
2018
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
public-library-of-science.
2015
The most significant SNPs in the transport pathway genes and risk of EOC by histology, invasiveness, and race/ethnicity1..
public-library-of-science.
2015
Top SNPs associated with SER EOC across racial groups..
public-library-of-science.
2015
-
hide from search
-
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
Gynecologic Oncology.
2013
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.
Cancer Epidemiology Biomarkers & Prevention.
2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies.
Cancer Causes & Control.
2013
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer.
Cancer Epidemiology Biomarkers & Prevention.
2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Nature Communications.
2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Nature Genetics.
2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
The Lancet Oncology.
2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Nature Communications.
2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics.
2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
Endocrine Related Cancer.
2013
Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer.
Cancer Causes & Control.
2013
Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
Cancer Causes & Control.
2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
BMC Cancer.
2013
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.
International Journal of Epidemiology.
2013
DistributionA of selected
characteristics between cases and controls..
public-library-of-science.
2011
Odds ratios (OR) and 95% confidence intervals (CI)A between variants in
DCN and LUM genes and serous
epithelial ovarian cancer risk..
public-library-of-science.
2011
Per-allele odds ratios (OR) and 95% confidence intervals (CI) at
DCN rs3138165 with serous epithelial ovarian cancer
across strata of risk factors..
public-library-of-science.
2011
Polymorphisms in Stromal Genes and Susceptibility to Serous
Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association
Consortium.
public-library-of-science.
2011
Combined discovery and replication analysis: risk estimates for TERT rs7726159 for all races according to tumor behaviour and histological subtypes..
public-library-of-science.
2010
Combined discovery and replication analysis: site-specific and combined risk estimates for serous ovarian cancer for TERT rs7726159 among non-Hispanic whites..
public-library-of-science.
2010
Discovery analysis: risk estimates for serous ovarian cancer for three SNPs selected for replication by 16 OCAC studies..
public-library-of-science.
2010
Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”.
public-library-of-science.
2010
Replication analysis: risk estimates for serous invasive ovarian cancer in non-Hispanic whites for SNPs selected for replication by indicated OCAC sites..
public-library-of-science.
2010
AML experiment-wise test results for genotyping groups..
public-library-of-science.
2009
All 22 SNPs with significant associations identified using the trend test for association..
public-library-of-science.
2009
Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer.
public-library-of-science.
2009